Back to Search
Start Over
Lymphopenia is not associated with efficacy and risk of adverse events in a real-life MS population treated with fingo-limod and dimethyl fumarate
- Authors :
- Bruschi, N.
Boffa, G.
Cellerino, M.
Sbragia, E.
Novi, G.
Lapucci, C.
Carpaneto, S.
Laroni, A.
Capello, E.
Antonio UCCELLI
Inglese, M.
- Source :
- Publons
Details
- Database :
- OpenAIRE
- Journal :
- Publons
- Accession number :
- edsair.dedup.wf.001..4b6759d350c017b40ec3ec87cf7b9100